NTLA — INTELLIA THERAPEUTICS Share News
0.000.00%
Last trade - 00:00- $1.56bn
- $1.13bn
- $67.67m
U.S. STOCKS ON THE MOVE-Palantir Technologies, Cheniere Energy, Venture Global
Intellia rises after US FDA lifts hold on heart disease gene therapy trial
U.S. STOCKS ON THE MOVE -Duolingo, AES, NextDecade
Brief: Intellia Therapeutics Inc - Increases At-The-Market Offering Program To $1.04 Billion- SEC Filing
Intellia rises after US FDA lifts clinical hold on heart disease gene therapy trial
US FDA lifts clinical hold on Intellia's heart disease gene therapy trial (updated)
US FDA lifts clinical hold on Intellia's heart disease gene therapy trial
Brief: Intellia Therapeutics Announces FDA Lift Of Clinical Hold On Magnitude Phase 3 Clinical Trial In Attr-Cm
Intellia Therapeutics Q4 collaboration revenue rises, net loss narrows
Brief: Intellia Therapeutics Q4 Net Income USD -95.786 Million
U.S. STOCKS ON THE MOVE.-CoreWeave, Texas Instruments, Richtech Robotics
U.S. STOCKS ON THE MOVE-Sysco, Corning, HCA Healthcare
U.S. STOCKS ON THE MOVE-RTX, Kimberly-Clark, HCA Healthcare
Intellia gets FDA nod to resume gene therapy trial after safety pause (updated)
Intellia jumps as FDA lifts hold on gene‑editing trial for rare nerve disease
US FDA lifts clinical hold on Intellia’s nerve disease trail
Brief: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Akamai Technologies, Enbridge, KKR
U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive